Pharma

ALK’s Grazax in five-year landmark asthma prevention trial in children sees … – The Pharma Letter (registration)

ALK's Grazax in five-year landmark asthma prevention trial in children sees …The Pharma Letter (registration)Denmark-based allergy specialist ALK Abello (ALKB: DC) has announced disappointing top-line results from the Grazax Asthma Prevention (GAP) trial with ALK's allergy immunotherapy tablet against grass…